Bradley L. Campbell
2012
In 2012, Bradley L. Campbell earned a total compensation of $1M as President and chief operating officer at Amicus Therapeutics, a 32% increase compared to previous year.
Compensation breakdown
| Bonus | $117,640 |
|---|---|
| Option Awards | $544,845 |
| Salary | $340,000 |
| Other | $14,765 |
| Total | $1,017,250 |
Campbell received $544.8K in option awards, accounting for 54% of the total pay in 2012.
Campbell also received $117.6K in bonus, $340K in salary and $14.8K in other compensation.
Rankings
In 2012, Bradley L. Campbell's compensation ranked 6,059th out of 11,487 executives tracked by ExecPay. In other words, Campbell earned more than 47.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,059 out of 11,487 | 47th |
Division Manufacturing | 2,150 out of 4,253 | 49th |
Major group Chemicals And Allied Products | 542 out of 1,198 | 55th |
Industry group Drugs | 369 out of 920 | 60th |
Industry Pharmaceutical Preparations | 292 out of 700 | 58th |
Source: SEC filing on April 28, 2015.
Campbell's colleagues
We found five more compensation records of executives who worked with Bradley L. Campbell at Amicus Therapeutics in 2012.
2012
John Crowley
Amicus Therapeutics
Chief Executive Officer
2012
David Lockhart
Amicus Therapeutics
Chief Scientific Officer
2012
William Baird
Amicus Therapeutics
Chief Financial Officer
2012
Pol Boudes
Amicus Therapeutics
Chief Medical Officer
2012
Daphne Quimi
Amicus Therapeutics